Venkataraman Balasubramanian

Array ( [id] => 5973662 [patent_doc_number] => 20110152552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'PREPARATION OF BILE ACIDS AND INTERMEDIATES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/010727 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8110 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152552.pdf [firstpage_image] =>[orig_patent_app_number] => 13010727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549529 [patent_doc_number] => 08324412 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Method for preparing 4-[17β-methoxy-17α-methoxymethyl-3-oxoestra-4,9-dien-11β-yl]benzaldehyde (E)-oxime (asoprisnil)' [patent_app_type] => utility [patent_app_number] => 12/987850 [patent_app_country] => US [patent_app_date] => 2011-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7741 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 259 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12987850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648714 [patent_doc_number] => 08802727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'Pharmaceutically acceptable salts of betulinic acid derivatives' [patent_app_type] => utility [patent_app_number] => 12/987228 [patent_app_country] => US [patent_app_date] => 2011-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 14805 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12987228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8612716 [patent_doc_number] => 20130018027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR NON-TOXIC DELIVERY OF ANTIPROGESTINS' [patent_app_type] => utility [patent_app_number] => 13/636119 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14572 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8442392 [patent_doc_number] => 20120259007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'ANTICOAGULANT COMPOUNDS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/518618 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9121 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038339 [patent_doc_number] => 20110091388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/974693 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 51276 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091388.pdf [firstpage_image] =>[orig_patent_app_number] => 12974693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8842256 [patent_doc_number] => 20130137884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID' [patent_app_type] => utility [patent_app_number] => 13/140421 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 34142 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8510321 [patent_doc_number] => 20120309728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'NEW STEROID INHIBITORS OF PGP FOR USE FOR INHIBITING MULTIDRUG RESISTANCE' [patent_app_type] => utility [patent_app_number] => 13/516860 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30671 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033935 [patent_doc_number] => 20110082305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => '7-Phenyl-Substituted Tetracycline Compounds' [patent_app_type] => utility [patent_app_number] => 12/967906 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8319 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082305.pdf [firstpage_image] =>[orig_patent_app_number] => 12967906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6120970 [patent_doc_number] => 20110077225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => '4-Substituted Tetracyclines and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/962293 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13903 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077225.pdf [firstpage_image] =>[orig_patent_app_number] => 12962293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580881 [patent_doc_number] => 20110294764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => '2-METHYLENE-19,26-NOR-(20S)-1alpha-HYDROXYVITAMIN D3' [patent_app_type] => utility [patent_app_number] => 12/955567 [patent_app_country] => US [patent_app_date] => 2010-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8515 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294764.pdf [firstpage_image] =>[orig_patent_app_number] => 12955567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482924 [patent_doc_number] => 20120282331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'MAMMALIAN METABOLITES OF STEROIDS' [patent_app_type] => utility [patent_app_number] => 13/508726 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 21654 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071551 [patent_doc_number] => 20110046402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'NOVEL METHOD AND INTERMEDIATES FOR PREPARING 19-NORSTEROID COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/915966 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11752 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046402.pdf [firstpage_image] =>[orig_patent_app_number] => 12915966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5930279 [patent_doc_number] => 20110040082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'Modifications of antimetabolite gemcitabine for incorporation in CpG oligonucleotides' [patent_app_type] => utility [patent_app_number] => 12/925494 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5908 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20110040082.pdf [firstpage_image] =>[orig_patent_app_number] => 12925494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196953 [patent_doc_number] => 20110028711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Unsaturated Steroid Compounds' [patent_app_type] => utility [patent_app_number] => 12/905778 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16893 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028711.pdf [firstpage_image] =>[orig_patent_app_number] => 12905778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127744 [patent_doc_number] => 20110086822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'Substituted Tetracycline Compounds' [patent_app_type] => utility [patent_app_number] => 12/901196 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25414 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086822.pdf [firstpage_image] =>[orig_patent_app_number] => 12901196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9827966 [patent_doc_number] => 08937193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-20 [patent_title] => 'Apogossypolone derivatives as anticancer agents' [patent_app_type] => utility [patent_app_number] => 12/900378 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 33512 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12900378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127740 [patent_doc_number] => 20110086821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'Tetracycline Compounds for Treatment of Cryptosporidium Parvum Related Disorders' [patent_app_type] => utility [patent_app_number] => 12/897459 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7309 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086821.pdf [firstpage_image] =>[orig_patent_app_number] => 12897459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149885 [patent_doc_number] => 20110021480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => '17-beta HSD1 and STS Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/892351 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57892 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021480.pdf [firstpage_image] =>[orig_patent_app_number] => 12892351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453864 [patent_doc_number] => 20120264810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING CELLULAR UPTAKE AND INTRACELLULAR DELIVERY OF LIPID PARTICLES' [patent_app_type] => utility [patent_app_number] => 13/497395 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 41374 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497395 [rel_patent_id] =>[rel_patent_doc_number] =>)